These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28482330)

  • 41. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of endometriosis with dienogest: preliminary report].
    Kamiński K; Fiegler P; Marr J; Moore C
    Ginekol Pol; 2001 May; 72(5):299-304. PubMed ID: 11526761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dienogest: a new therapeutic agent for the treatment of endometriosis.
    Harada T; Taniguchi F
    Womens Health (Lond); 2010 Jan; 6(1):27-35. PubMed ID: 20001868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest.
    Nikschick S; Köhler G; Männchen E
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):211-4. PubMed ID: 2689190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis.
    Jeong SH; Lee D; Kim SK; Jee BC
    Gynecol Endocrinol; 2018 Nov; 34(11):970-974. PubMed ID: 29733226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
    Mabrouk M; Paradisi R; Arena A; Del Forno S; Matteucci C; Zannoni L; Caprara G; Seracchioli R
    Gynecol Endocrinol; 2018 May; 34(5):399-403. PubMed ID: 29160135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study.
    Angioni S; Nappi L; Pontis A; Sedda F; Luisi S; Mais V; Melis GB
    Gynecol Endocrinol; 2015 May; 31(5):406-8. PubMed ID: 25776993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
    Yanase T; Tsuneki I; Tamura M; Kurabayashi T
    Gynecol Endocrinol; 2014 Nov; 30(11):804-7. PubMed ID: 25060125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
    Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
    Hum Reprod; 2010 Mar; 25(3):633-41. PubMed ID: 20089522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor.
    Yazdani S; Kasajima A; Ogata H; Felizola SJ; Nakamura Y; Onodera Y; Watanabe M; Motoi F; Unno M; Sasano H
    Neuroendocrinology; 2015; 101(4):309-20. PubMed ID: 25791399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dienogest for the treatment of deep endometriosis: case report and literature review.
    Agarwal S; Fraser MA; Chen I; Singh SS
    J Obstet Gynaecol Res; 2015 Feb; 41(2):309-13. PubMed ID: 25303112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells.
    Lesmeister MJ; Jorgenson RL; Young SL; Misfeldt ML
    Reprod Biol Endocrinol; 2005 Dec; 3():74. PubMed ID: 16384532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis.
    Köhler G; Faustmann TA; Gerlinger C; Seitz C; Mueck AO
    Int J Gynaecol Obstet; 2010 Jan; 108(1):21-5. PubMed ID: 19819448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacological and clinical profile of dienogest (DINAGEST Tab. 1 mg)].
    Sasagawa S; Shimizu Y; Imada K; Mizuguchi K
    Nihon Yakurigaku Zasshi; 2009 Jan; 133(1):32-40. PubMed ID: 19145049
    [No Abstract]   [Full Text] [Related]  

  • 56. Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells.
    Akoum A; Lemay A; Maheux R
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5785-92. PubMed ID: 12466387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice.
    Römer T
    Arch Gynecol Obstet; 2018 Oct; 298(4):747-753. PubMed ID: 30076546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
    Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
    J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of premenstrual mood changes in a patient with schizophrenia using dienogest: A case report.
    Kamada Y; Sakamoto A; Kotani S; Masuyama H
    J Obstet Gynaecol Res; 2018 Apr; 44(4):797-800. PubMed ID: 29359527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacology of dienogest.
    Ruan X; Seeger H; Mueck AO
    Maturitas; 2012 Apr; 71(4):337-44. PubMed ID: 22364708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.